化合物 T10476
|
|
|
- CAS号:
- 2471967-92-5
- 英文名:
- 1,6-Naphthyridine-6(5H)-carboxamide, N-[2-(4-fluorophenoxy)-5-pyrimidinyl]-5-(4-fluorophenyl)-7,8-dihydro-, (5S)-
- 英文别名:
- BAY-899;1,6-Naphthyridine-6(5H)-carboxamide, N-[2-(4-fluorophenoxy)-5-pyrimidinyl]-5-(4-fluorophenyl)-7,8-dihydro-, (5S)-
- 中文名:
- 化合物 T10476
- 中文别名:
- 化合物 T10476
- CBNumber:
- CB88186364
- 分子式:
- C25H19F2N5O2
- 分子量:
- 459.45
- MOL File:
- 2471967-92-5.mol
|
|
|
化合物 T10476化学性质
-
密度:
-
1.397±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
酸度系数(pKa):
-
12.52±0.40(Predicted)
-
|
化合物 T10476性质、用途与生产工艺
BAY-899 是一种口服有效和选择性的促黄体生成激素受体 (LH-R) 拮抗剂，对 hLH (人 LH) 和 rLH (大鼠 LH) 的 IC50 分别为 185 nM 和 46 nM。BAY-899 可以降低性激素水平。
IC50: 185 nM (hLH) and 46nM (rLH)
BAY-899 (oral; 12.5 mg/kg/day; for 8 days) shows an efficiency to reduce serum estradiol levels in intact female rats.
BAY-899 (iv of 0.5 mg/kg or po of 2 mg/kg) has a t
1/2
of 11 hours and 12 hours for iv and po. And the C
max
is 0.97 kg/L and 0.24 kg/L for iv and po.
|
Animal Model:
|
Intact female rats
|
|
Dosage:
|
12.5 mg/kg
|
|
Administration:
|
Oral; for 8 days
|
|
Result:
|
Showed an efficiency to reduce serum estradiol levels.
|
|
Animal Model:
|
Female and male Wistar rats
|
|
Dosage:
|
0.5 mg/kg of iv or 2 mg/kg of po
|
|
Administration:
|
Iv or po
|
|
Result:
|
Has t
1/2
s of 11 hours and 12 hours for iv and po. And the C
max
s are 0.97 kg/L and 0.24 kg/L for iv and po.
|
化合物 T10476
上下游产品信息
上游原料
下游产品
2471967-92-5, 化合物 T10476 相关搜索:
- APIs
- C25H19F2N5O2
- 化合物 T10476
- 2471967-92-5
- BAY-899
- 1,6-Naphthyridine-6(5H)-carboxamide, N-[2-(4-fluorophenoxy)-5-pyrimidinyl]-5-(4-fluorophenyl)-7,8-dihydro-, (5S)-